Clinical Trial Update: Pre-operative Polyethylene Glycol 3350 for Minimally Invasive Urogynecologic Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating pre-operative polyethylene glycol 3350 for minimally invasive urogynecologic surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Pelvic Organ Prolapse

Drugs mentioned

• Polyethylene glycol 3350 (polyethylene glycol 3350)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Constipation, Surgical Procedure, Unspecified | Phase 4 | Status: COMPLETED